Katie Palmer

@katiepalmer.bsky.social

Health tech correspondent at STAT News (www.statnews.com) Share tips: katie.palmer@statnews.com Signal: palmer.01

For 3 years, I've reported on 2 big telehealth trends: pharma partnerships and compounding. They've gone head-to-head as patients demand GLP-1s. But they've been part of the same story for much longer. Here's how telehealth got hooked on drug-first thinking: www.statnews.com/2025/10/06/t...

From erectile dysfunction to weight loss, how telehealth got hooked on drug-first thinking

Marketing of on-demand telehealth prescriptions has rapidly become a constant presence for American consumers

statnews.com

It's been 6 months since the FDA updated its public list of authorized AI-enabled devices. So @statnews.com went ahead and checked how things are going. At least 167 more AI-enabled devices have gotten cleared or approved since the last one added to FDA's list: www.statnews.com/2025/06/20/f...

As AI device market grows, FDA's accounting goes silent

As the market for AI enabled medical devices grows, experts say there is less transparency around device approvals.

statnews.com

May 1 is the deadline for health systems to make sure that AI and other tools informing patient care don't discriminate. But the Trump admin scrubbed information about the civil rights rule months ago. What does that mean for compliance? My latest for @statnews.com www.statnews.com/2025/04/30/h...

Health systems in limbo as HHS stays quiet on nondiscrimination rules for AI, algorithms

Lack of clarity from officials delay providers' efforts to ensure clinical decision support tools don't discriminate.

statnews.com

Work on insuring clinical algorithms are free of bias has been underway for years. Now a May 1 deadline to show tools are bias-free is in limbo as all information about the new rules have been removed from HHS websites. More from @katiepalmer.bsky.social www.statnews.com/2025/04/30/h...

Health systems in limbo as HHS stays quiet on nondiscrimination rules for AI, algorithms

Lack of clarity from officials delay providers' efforts to ensure clinical decision support tools don't discriminate.

statnews.com

The explosion of compounded GLP-1 offerings is ending, and many patients are left with no good options. Telehealth companies and compounders are pursuing workarounds that may be riskier. At the same time, patients still can't afford the branded drugs. w/ @katiepalmer.bsky.social

The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from

statnews.com

In 2026, HHS was set to require fields for sexual orientation and gender identity in EHRs, supporting research and better care for LGBTQ+ patients. Now, HHS won't enforce those requirements. Read in @statnews.com about impacts on providers and EHR vendors: www.statnews.com/2025/04/01/h...

HHS will not enforce gender and sexual orientation requirements for medical records

HHS will not enforce standards that medical records be able to capture patients’ sexual orientation and gender identity.

statnews.com

Facing a shrinking market for compounded GLP-1 weight loss drugs, dozens of telehealth companies are marketing hormone therapies for men and women — many of them compounded options that use the same backbone built to capitalize on intense GLP-1 demand www.statnews.com/2025/03/11/t...

As GLP-1 compounding stares down a wall, telehealth companies pivot to hormones

As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.

statnews.com

In today's edition of AI Prognosis we: -Address the question of whether health care's adoption of AI scribes is entirely vibes-based -Have an exclusive Q&A with co-founder of an AI deep research tool made specifically for scientists who just raised a $22M Series A -Recommend a 🔥 Song of the Week

Are we adopting AI scribes based on... vibes?

The web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health care and medicine.

statnews.com

As a health tech reporter at STAT News, I cover the role of technology in health care and clinical research — including artificial intelligence, telehealth, EHRs, and remote patient monitoring. Is there an untold story about how tech is impacting patients? Contact me securely on Signal: palmer.01

FDA's AI device count has now ticked over 1,000. But it has also quietly received over 500 drug submissions with AI, and today it put out an anticipated draft guidance on AI in drug development. What does high-risk AI in drugs mean to FDA? Read in @statnews.com: www.statnews.com/2025/01/06/a...

FDA's new guidance on AI in drug development centers the risk introduced by the technology

After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug development.

statnews.com

NEW: Some consider him a fearless truth-teller with a deep respect for science. Others consider him a contrarian for contrarian’s sake, opining on matters for political clout. Which Marty Makary would run the FDA? www.statnews.com/2024/12/17/m...

Truth-teller or reflexive contrarian: Which Marty Makary would run the FDA?

Pancreatic surgeon Marty Makary is a long-time critic of the medical establishment who's now set to regulate food, drugs, and medical devices at the FDA.

statnews.com

A surprising finding in this analysis of FDA-authorized AI/ML devices: 22 devices indicated for use in kids were validated in adult datasets only. That's part of a much broader problem in how representative (or not) AI devices' training and validation data are: www.statnews.com/2024/12/16/f...

FDA authorizes many AI devices for use in kids. Are they validated in a pediatric population?

A new study resurfaces long-simmering concerns about the lack of transparency in data used to train and validate AI and ML-enabled devices.

statnews.com

This is astonishing especially because self-reported large health data breaches hit an all-time high last year, impacting more than 165 million individuals — half the U.S. population. Imagine how much higher the number would be if OCR did regular audits.

Health data breaches hit an all-time high in 2023

At least 116 million individuals were impacted by large and numerous health data breaches reported to federal regulators this year.

statnews.com

Brittany Trang@brittanytrang.com · 2y ago

New @statnews.bsky.social from me: HHS' Office of Civil Rights hasn't audited HIPAA compliance since 2017. These audits, required by the HITECH Act, are supposed to assess things like cybersecurity readiness, but even when it conducted audits, OCR only looked at 8 of 180 #HIPAA rules 😳 More: 🩺🖥️

Will the FDA's advisory committee meeting on generative AI in medical devices this week surface productive solutions for regulation, or will it be "a lot of hand-waving and overpromising"? We'll be watching: www.statnews.com/2024/11/19/f...

In first meeting of FDA’s digital health advisory committee, generative AI is up for debate

The FDA's digital health advisory committee is expected to weigh in on how generative AI should be regulated by the agency.

statnews.com

Clinicians have long discouraged using Google Translate to get important messages across to patients with limited English. Now some health systems, including Children's Hospital Los Angeles, are turning to LLMs to translate key documents. For @statnews.bsky.social: www.statnews.com/2024/11/11/c...

Children’s Hospital Los Angeles tests generative AI to translate discharge notes into Spanish

Children's Hospital Los Angeles is testing generative AI to translate discharge notes for Spanish-speaking patients in seconds

statnews.com